| Study ID |
B.L. ICS dose |
B.L. FEV1 (% pred) |
B.L. symp freq |
| Baran 1987 |
not stated |
not stated |
not stated |
| Bjorkander 1982 |
not stated |
>70 |
not stated |
| Boe 1989 |
ICS 400‐800 mcg/d |
not stated |
not stated |
| Brambilla 1994 |
BDP 1000‐2000 mcgd |
not stated |
recurrent acute exacerbations of dyspoea and wheezing |
| Dal Negro 1997 |
BDP 1000 mcg/d |
not stated |
not stated |
| Ebden 1986 |
not stated |
not stated |
not clearly stated but in opinion of investigator patients were poorly controlled |
| Field 1982 |
not stated |
not stated |
not stated |
| Greefhorst 1992 |
not stated |
not stated |
not stated |
| Hamalainen 1998 |
BDP or BUD 800‐1000 mcg/d |
not stated |
not stated |
| Michleletto 1997 |
BDP 1000 mcg/d |
not stated |
not stated |
| Pedersen 1988 |
BDP or BUD 800‐1200 mcg/d |
not stated |
not stated |
| Petrie 1990 |
BDP or BUD 800‐1600 mcg/d |
mean 72%, range 34‐114) |
not stated |
| Selroos 1994 |
BDP 1000 mcg/d |
not stated but mean PEFR 75‐77% predicted |
not stated |
| Springer 1987 |
BDP 400 mcg/d |
not stated |
not stated |
| Svendsen 1993 |
ICS 300‐500 mcg/d |
<70 |
stated by authors that asthma was 'poorly controlled' |
| Tjwa 1995 |
ICS 150‐800 mcg/d |
40‐85 |
not stated |
| Willey 1982 |
BDP 400 mcg/d or greater |
not stated |
symptom frequency not stated, but at least 2 courses or oral steroids in last 12 months for exacerbations |
| |
|
|
|
| B.L: baseline |
|
|
|
